Rivaroxaban Seems Safe, Effective for Pediatric Acute VTE

Press/Media: Other

Period14 Nov 2019

Media contributions


Media contributions

  • TitleRivaroxaban Seems Safe, Effective for Pediatric Acute VTE
    Degree of recognitionInternational
    Media name/outletMedscape WebMD LLC
    Media typeWeb
    Country/TerritoryUnited States
    DescriptionNEW YORK (Reuters Health) - In children with acute venous thromboembolism (VTE), treatment with the direct oral anticoagulant rivaroxaban results in a similarly low recurrence risk and a lower thrombotic burden as parenteral anticoagulants, without increasing bleeding, researchers say.
    Producer/AuthorMarilynn Larkin
    PersonsОльга Александровна Львова